Michael Brennan to Salivary Gland Diseases
This is a "connection" page, showing publications Michael Brennan has written about Salivary Gland Diseases.
Connection Strength
0.549
-
Mercadante V, Jensen SB, Smith DK, Bohlke K, Bauman J, Brennan MT, Coppes RP, Jessen N, Malhotra NK, Murphy B, Rosenthal DI, Vissink A, Wu J, Saunders DP, Peterson DE. Salivary Gland Hypofunction and/or Xerostomia Induced by Nonsurgical Cancer Therapies: ISOO/MASCC/ASCO Guideline. J Clin Oncol. 2021 09 01; 39(25):2825-2843.
Score: 0.206
-
Stoopler ET, Shirlaw P, Arvind M, Lo Russo L, Bez C, De Rossi S, Garfunkel AA, Gibson J, Liu H, Liu Q, Thongprasom K, Wang Q, Greenberg MS, Brennan MT. An international survey of oral medicine practice: proceedings from the 5th World Workshop in Oral Medicine. Oral Dis. 2011 Apr; 17 Suppl 1:99-104.
Score: 0.101
-
Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napeñas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bültzingslöwen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer. 2010 Aug; 18(8):1061-79.
Score: 0.094
-
Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, Davies AN, Dutilh J, Fulton JS, Jankovic L, Lopes NN, Mello AL, Muniz LV, Murdoch-Kinch CA, Nair RG, Napeñas JJ, Nogueira-Rodrigues A, Saunders D, Stirling B, von Bültzingslöwen I, Weikel DS, Elting LS, Spijkervet FK, Brennan MT. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer. 2010 Aug; 18(8):1039-60.
Score: 0.094
-
Brennan MT, Shariff G, Lockhart PB, Fox PC. Treatment of xerostomia: a systematic review of therapeutic trials. Dent Clin North Am. 2002 Oct; 46(4):847-56.
Score: 0.056